Clinical Guidelines for the Antibiotic Treatment for Community-Acquired Skin and Soft Tissue Infection
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kwak, Yee Gyung | - |
dc.contributor.author | Choi, Seong-Ho | - |
dc.contributor.author | Kim, Tark | - |
dc.contributor.author | Park, Seong Yeon | - |
dc.contributor.author | Seo, Soo-Hong | - |
dc.contributor.author | Kim, Min Bom | - |
dc.contributor.author | Choi, Sang-Ho | - |
dc.date.accessioned | 2021-09-02T22:17:10Z | - |
dc.date.available | 2021-09-02T22:17:10Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2017-12 | - |
dc.identifier.issn | 2093-2340 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/81306 | - |
dc.description.abstract | Skin and soft tissue infection (SSTI) is common and important infectious disease. This work represents an update to 2012 Korean guideline for SSTI. The present guideline was developed by the adaptation method. This clinical guideline provides recommendations for the diagnosis and management of SSTI, including impetigo/ecthyma, purulent skin and soft tissue infection, erysipelas and cellulitis, necrotizing fasciitis, pyomyositis, clostridial myonecrosis, and human/animal bite. This guideline targets community-acquired skin and soft tissue infection occurring among adult patients aged 16 years and older. Diabetic foot infection, surgery-related infection, and infections in immunocompromised patients were not included in this guideline. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOC CHEMOTHERAPY | - |
dc.subject | DOG-BITE WOUNDS | - |
dc.subject | LOWER-EXTREMITY CELLULITIS | - |
dc.subject | EXPERIMENTAL GAS-GANGRENE | - |
dc.subject | TOXIC-SHOCK-SYNDROME | - |
dc.subject | STAPHYLOCOCCUS-AUREUS | - |
dc.subject | NECROTIZING FASCIITIS | - |
dc.subject | RISK-FACTORS | - |
dc.subject | DOUBLE-BLIND | - |
dc.subject | PROPHYLACTIC ANTIBIOTICS | - |
dc.subject | ADVISORY-COMMITTEE | - |
dc.title | Clinical Guidelines for the Antibiotic Treatment for Community-Acquired Skin and Soft Tissue Infection | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Seo, Soo-Hong | - |
dc.identifier.doi | 10.3947/ic.2017.49.4.301 | - |
dc.identifier.scopusid | 2-s2.0-85040023629 | - |
dc.identifier.wosid | 000419578400010 | - |
dc.identifier.bibliographicCitation | INFECTION AND CHEMOTHERAPY, v.49, no.4, pp.301 - 325 | - |
dc.relation.isPartOf | INFECTION AND CHEMOTHERAPY | - |
dc.citation.title | INFECTION AND CHEMOTHERAPY | - |
dc.citation.volume | 49 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 301 | - |
dc.citation.endPage | 325 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002304835 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Infectious Diseases | - |
dc.relation.journalWebOfScienceCategory | Infectious Diseases | - |
dc.subject.keywordPlus | DOG-BITE WOUNDS | - |
dc.subject.keywordPlus | LOWER-EXTREMITY CELLULITIS | - |
dc.subject.keywordPlus | EXPERIMENTAL GAS-GANGRENE | - |
dc.subject.keywordPlus | TOXIC-SHOCK-SYNDROME | - |
dc.subject.keywordPlus | STAPHYLOCOCCUS-AUREUS | - |
dc.subject.keywordPlus | NECROTIZING FASCIITIS | - |
dc.subject.keywordPlus | RISK-FACTORS | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordPlus | PROPHYLACTIC ANTIBIOTICS | - |
dc.subject.keywordPlus | ADVISORY-COMMITTEE | - |
dc.subject.keywordAuthor | Impetigo | - |
dc.subject.keywordAuthor | Erysipelas | - |
dc.subject.keywordAuthor | Cellulitis | - |
dc.subject.keywordAuthor | Fasciitis | - |
dc.subject.keywordAuthor | Pyomyositis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.